Sam S. Chang

19.6k total citations · 7 hit papers
209 papers, 9.9k citations indexed

About

Sam S. Chang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Sam S. Chang has authored 209 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Surgery, 49 papers in Pulmonary and Respiratory Medicine and 45 papers in Epidemiology. Recurrent topics in Sam S. Chang's work include Bladder and Urothelial Cancer Treatments (77 papers), Urinary and Genital Oncology Studies (44 papers) and Inflammatory Bowel Disease (44 papers). Sam S. Chang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (77 papers), Urinary and Genital Oncology Studies (44 papers) and Inflammatory Bowel Disease (44 papers). Sam S. Chang collaborates with scholars based in United States, Taiwan and Germany. Sam S. Chang's co-authors include Michael S. Cookson, Joseph A. Smith, Victor E. Reuter, Paul B. Gaudin, Raj S. Pruthi, Peter E. Clark, Eila C. Skinner, John D. Seigne, Roger Chou and Warren D.W. Heston and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sam S. Chang

191 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

2016 937 citations Sam S. Chang, Peter E. Clark et al. profile →
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

2017 768 citations Shiping Jiao, Weiya Xia et al. Clinical Cancer Research profile →
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

1999 703 citations Sam S. Chang et al. PubMed profile →
Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

2007 646 citations Sam S. Chang et al. profile →
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

2017 613 citations Sam S. Chang et al. profile →
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

2021 255 citations Zhou Jiang, Seung-Oe Lim et al. Journal of Clinical Investigation profile →
Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

2023 82 citations Peter E. Clark, Sam S. Chang et al. profile →

Peers

Countries citing papers authored by Sam S. Chang

Since Specialization

Citations

This map shows the geographic impact of Sam S. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam S. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam S. Chang more than expected).

Fields of papers citing papers by Sam S. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam S. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam S. Chang. The network helps show where Sam S. Chang may publish in the future.

Co-authorship network of co-authors of Sam S. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Sam S. Chang. A scholar is included among the top collaborators of Sam S. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam S. Chang. Sam S. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease 2025 ·Digestive Diseases and Sciences ·(unknown), Pakdee Rojanasopondist, (unknown), Cristina Fernández, (unknown), Alice Li, Nicole Werner, (unknown), Roberto Ortiz, Xinyu Wang, Megan E. Murphy, Jordan E. Axelrad, (unknown), Ariela Holmer, Sam S. Chang, David Hudesman, Seymour Katz, Lisa Malter, Adam S. Faye	0
2	A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch 2025 ·The American Journal of Gastroenterology ·Edward L. Barnes, Laura E. Raffals, Taha Qazi, Parakkal Deepak, Sam S. Chang, Poonam Beniwal‐Patel, Peter Higgins, Raymond K. Cross, (unknown), Chelsea Anderson, Millie D. Long, Hans Herfarth, Marla C. Dubinsky, Michael D. Kappelman, Maia Kayal	0
3	Low-cost and label-free blue light cystoscopy through digital staining of white light cystoscopy videos 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Kristen R. Scarpato, Amy N. Luckenbaugh, Sam S. Chang, Soheil Kolouri, Audrey K. Bowden	0
4	Validation of Keratin 17 as a tissue biomarker in the diagnosis of upper tract urothelial carcinoma 2024 ·Human Pathology ·(unknown), Nam Kim, (unknown), Mark Sarno, Sam S. Chang, Giovanna A. Giannico	0
5	652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) 2023 ·Annals of Oncology ·Kathryn C. Arbour, Salman R. Punekar, Ignacio Garrido‐Laguna, David S. Hong, Brian M. Wolpin, (unknown), (unknown), Alexander Starodub, (unknown), Sam S. Chang, (unknown), Zeena Salman, (unknown), Corinne E. Gustafson, Alexander I. Spira	70
6	Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch 2023 ·The American Journal of Gastroenterology ·Maia Kayal, Parakkal Deepak, Poonam Beniwal‐Patel, Laura E. Raffals, Marla C. Dubinsky, Sam S. Chang, Peter Higgins, Yue Jiang, Raymond K. Cross, Millie D. Long, Hans Herfarth, Edward L. Barnes	4
7	Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry 2022 ·Crohn s & Colitis 360 ·Edward L. Barnes, Parakkal Deepak, Poonam Beniwal‐Patel, Laura H. Raffals, Maia Kayal, Marla C. Dubinsky, Sam S. Chang, Peter Higgins, (unknown), Joseph A. Galanko, Yue Jiang, Raymond K. Cross, Millie D. Long, Hans Herfarth	9
8	Correlation between imaging findings on outpatient MR enterography (MRE) in adult patients with Crohn disease and progression to surgery within 5 years 2022 ·Abdominal Radiology ·Bari Dane, Kun Qian, (unknown), Paul Smereka, Jonathan K. Foster, Chenchan Huang, Sam S. Chang, Sooah Kim	7
9	Crohn Disease Active Inflammation Assessment with Iodine Density from Dual-Energy CT Enterography: Comparison with Histopathologic Analysis 2021 ·Radiology ·Bari Dane, Suparna A. Sarkar, (unknown), (unknown), Thomas O’Donnell, Feza H. Remzi, Sam S. Chang, Alec J. Megibow	34
10	TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis breakdown → 2021 ·Journal of Clinical Investigation ·Zhou Jiang, Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei, Sam S. Chang, Hirohito Yamaguchi, Heng‐Huan Lee, Baozhen Ke, Jung-Mao Hsu, Li-Chuan Chan, Gabriel N. Hortobágyi, Liuqing Yang, Chunru Lin, Dihua Yu, Mien‐Chie Hung	255
11	Effect of carbon dioxide versus room air insufflation on post-colonoscopic pain: A prospective, randomized, controlled study 2020 ·The Turkish Journal of Gastroenterology ·Feyza Gündüz, Haluk Tarık Kani, Sam S. Chang, Esra Akdenız, Fatih Eren, Yusuf Yılmaz, Yeşim Özen Alahdab	2
12	PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression breakdown → 2017 ·Clinical Cancer Research ·Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, Yongkun Wei, Mei‐Kuang Chen, Jung-Mao Hsu, Jennifer L. Hsu, Wen-Hsuan Yu, Yi Du, Heng‐Huan Lee, Chia‐Wei Li, Chao‐Kai Chou, Seung-Oe Lim, Sam S. Chang, Jennifer K. Litton, Banu Arun, Gabriel N. Hortobágyi, Mien‐Chie Hung	768
13	Cost considerations in the management of bladder cancer 2017 ·(unknown), Sam S. Chang	1
14	EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape 2016 ·Cancer Research ·Seung-Oe Lim, Chia‐Wei Li, Weiya Xia, Heng‐Huan Lee, Sam S. Chang, Jia Shen, Jennifer L. Hsu, Daniel Raftery, Danijel Djukovic, Haiwei Gu, Wei-Chao Chang, (unknown), Mong-Liang Chen, Longfei Huo, Chung‐Hsuan Chen, Yun Wu, Ayşegül A. Şahin, Samir Hanash, Gabriel N. Hortobágyi, Mien‐Chie Hung	203
15	Short term complications from transurethral resection of bladder tumor. 2016 ·PubMed ·Justin R. Gregg, Benjamin J. McCormick, Li Wang, Paul Cohen, Daniel Q. Sun, David F. Penson, Joseph A. Smith, Peter E. Clark, Michael S. Cookson, Daniel A. Barocas, Matthew J. Resnick, Kelvin A. Moses, Sam S. Chang	43
16	Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial–Mesenchymal Transition after Resection 2015 ·Clinical Cancer Research ·(unknown), Sam S. Chang, Chia‐Wei Li, Yi‐Hsin Elsa Hsu, Tse-Ching Chen, Wei‐Chen Lee, Chau‐Ting Yeh, Mien‐Chie Hung	25
17	The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer 2015 ·Clinical Cancer Research ·Shumei Song, Soichiro Honjo, Jiankang Jin, Sam S. Chang, Ailing W. Scott, Qiongrong Chen, Neda Kalhor, Arlene M. Correa, Wayne L. Hofstetter, Constance T. Albarracin, Tsung‐Teh Wu, Randy L. Johnson, Mien‐Chie Hung, Jaffer A. Ajani	200
18	Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells 2013 ·Clinical Cancer Research ·Hirohito Yamaguchi, Jennifer L. Hsu, Chun‐Te Chen, Ying‐Nai Wang, Ming‐Chuan Hsu, Sam S. Chang, Yi Du, How-Wen Ko, Roy S. Herbst, Mien‐Chie Hung	110
19	Current controversies in the treatment of high-risk prostate cancer 2008 ·Current Opinion in Urology ·Robert E. Mitchell, Sam S. Chang	18
20	The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA 2002 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Joseph A. Smith, Scott B. Shappell, Christopher S. Coffey, Sam S. Chang, Michael S. Cookson	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact